PDB,Iridium,Description,Resolution (A),Method,Title,Ligands (short),Ligands (long)
1A28,HT,progesterone receptor,1.8,X-Ray,HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN,STR,PROGESTERONE
1AI5,HT,penicillin amidohydrolase,2.36,X-Ray,PENICILLIN ACYLASE COMPLEXED WITH M-NITROPHENYLACETIC ACID,MNP; CA,2-(3-NITROPHENYL)ACETIC ACID; CALCIUM ION
1AZM,HT,carbonic anhydrase i,2,X-Ray,DRUG-PROTEIN INTERACTIONS: STRUCTURE OF SULFONAMIDE DRUG COMPLEXED WITH HUMAN CARBONIC ANHYDRASE I,AZM; ZN,"5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE; ZINC ION"
1B9V,HT,protein (neuraminidase),2.35,X-Ray,NOVEL AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE MAKE SELECTIVE INTERACTIONS WITH CONSERVED RESIDUES AND WATER MOLECULES IN TEH ACTIVE SITE,RA2; NAG; CA,"1-[4-CARBOXY-2-(3-PENTYLAMINO)PHENYL]-5,5'-DI(HYDROXYMETHYL)PYRROLIDIN-2-ONE; N-ACETYL-D-GLUCOSAMINE; CALCIUM ION"
1BR6,HT,protein (ricin),2.3,X-Ray,RICIN A CHAIN (RECOMBINANT) COMPLEX WITH PTEROIC ACID,PT1,PTEROIC ACID
1C1B,HT,hiv-1 reverse transcriptase (a-chain),2.5,X-Ray,CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA-186,CSD; GCA,"3-SULFINOALANINE; 6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL"
1CTR,HT,calmodulin,2.45,X-Ray,DRUG BINDING BY CALMODULIN: CRYSTAL STRUCTURE OF A CALMODULIN-TRIFLUOPERAZINE COMPLEX,CA; TFP,CALCIUM ION; 10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE
1CVU,HT,prostaglandin h2 synthase-2,2.4,X-Ray,CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO THE CYCLOOXYGENASE ACTIVE SITE OF COX-2,BOG; NAG; ACD; MAN,B-OCTYLGLUCOSIDE; N-ACETYL-D-GLUCOSAMINE; ARACHIDONIC ACID; ALPHA-D-MANNOSE
1CX2,HT,cyclooxygenase-2,3,X-Ray,"CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A SELECTIVE INHIBITOR, SC-558",S58; NAG; HEM,1-PHENYLSULFONAMIDE-3-TRIFLUOROMETHYL-5-PARABROMOPHENYLPYRAZOLE; N-ACETYL-D-GLUCOSAMINE; PROTOPORPHYRIN IX CONTAINING FE
1D3H,HT,dihydroorotate dehydrogenase,1.8,X-Ray,HUMAN DIHYDROOROTATE DEHYDROGENASE COMPLEXED WITH ANTIPROLIFERATIVE AGENT A771726,FMN; A26; ACT; ORO; SO4,FLAVIN MONONUCLEOTIDE; (2Z)-2-CYANO-3-HYDROXY-N-[4-(TRIFLUOROMETHYL)PHENYL]BUT-2-ENAMIDE; ACETATE ION; OROTIC ACID; SULFATE ION
1DD7,HT,inducible nitric oxide synthase,2.25,X-Ray,"MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) (N-[(1,3-BENZODIOXOL-5-YL)METHYL]-1-[2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL]-4-(METHOXYCARBONYL)-PIPERAZINE-2-ACETAMIDE COMPLEX",1PM; SO3; HEM,"METHYL (3S)-3-{2-[(1,3-BENZODIOXOL-5-YLMETHYL)AMINO]-2-OXOETHYL}-4-[2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL]PIPERAZINE-1-CARBOXYLATE; SULFITE ION; PROTOPORPHYRIN IX CONTAINING FE"
1DDS,HT,dihydrofolate reductase,2.2,X-Ray,MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE,MTX; CL; CA,METHOTREXATE; CHLORIDE ION; CALCIUM ION
1EOC,HT,"protocatechuate 3,4-dioxygenase alpha chain",2.25,X-Ray,"CRYSTAL STRUCTURE OF ACINETOBACTER SP. ADP1 PROTOCATECHUATE 3,4-DIOXYGENASE IN COMPLEX WITH 4-NITROCATECHOL",FE; 4NC,FE (III) ION; 4-NITROCATECHOL
1EXA,HT,retinoic acid receptor gamma-2,1.59,X-Ray,ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE ACTIVE R-ENANTIOMER BMS270394.,LMU; 394,"DODECYL-ALPHA-D-MALTOSIDE; R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOICACID"
1EZQ,HT,coagulation factor xa,2.2,X-Ray,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515,RPR; CA,3-[(3'-AMINOMETHYL-BIPHENYL-4-CARBONYL)-AMINO]-2-(3-CARBAMIMIDOYL-BENZYL)-BUTYRIC ACID METHYL ESTER; CALCIUM ION
1F0S,HT,coagulation factor xa,2.1,X-Ray,Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707,CA; PR2,"CALCIUM ION; THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE"
1F0T,HT,trypsin,1.8,X-Ray,BOVINE TRYPSIN COMPLEXED WITH RPR131247,CA; SO4; PR1,"CALCIUM ION; SULFATE ION; 4-HYDROXY-3-[2-OXO-3-(THIENO[3,2-B]PYRIDINE-2-SULFONYLAMINO)-PYRROLIDIN-1-YLMETHYL]-BENZAMIDINE"
1F0U,HT,trypsin,1.9,X-Ray,BOVINE TRYPSIN COMPLEXED WITH RPR128515,RPR; CA; SO4,3-[(3'-AMINOMETHYL-BIPHENYL-4-CARBONYL)-AMINO]-2-(3-CARBAMIMIDOYL-BENZYL)-BUTYRIC ACID METHYL ESTER; CALCIUM ION; SULFATE ION
1FCX,HT,retinoic acid receptor gamma-1,1.47,X-Ray,ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID BMS184394,184; LMU,"6-[HYDROXY-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTALEN-2-YL)-METHYL]-NAPHTALENE-2-CARBOXYLIC ACID; DODECYL-ALPHA-D-MALTOSIDE"
1FCZ,HT,retinoic acid receptor gamma-1,1.38,X-Ray,ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156,156; LMU,"4-[3-OXO-3-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-PROPENYL]-BENZOIC ACID; DODECYL-ALPHA-D-MALTOSIDE"
1FH8,HT,"beta-1,4-xylanase",1.95,X-Ray,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED ISOFAGOMINE INHIBITOR,XYP; XIF,"BETA-D-XYLOPYRANOSE; PIPERIDINE-3,4-DIOL"
1FH9,HT,"beta-1,4-xylanase",1.72,X-Ray,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM OXIME INHIBITOR,LOX; XYP,"3,4,5-TRIHYDOXY-PIPERIDINE-2-ONE-OXIME; BETA-D-XYLOPYRANOSE"
1FHD,HT,"beta-1,4-xylanase",1.9,X-Ray,CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED IMIDAZOLE INHIBITOR,XIM; XYP,"5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL; BETA-D-XYLOPYRANOSE"
1FJS,HT,coagulation factor xa,1.92,X-Ray,CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA,Z34; CA; GOL; CL,"N-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-3,5-DIFLUORO-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDIN-4-YL]-N-METHYLGLYCINE; CALCIUM ION; GLYCEROL; CHLORIDE ION"
1FL3,HT,blue fluorescent antibody (19g2)-heavy chain,2.45,X-Ray,CRYSTAL STRUCTURE OF THE BLUE FLUORESCENT ANTIBODY (19G2) IN COMPLEX WITH STILBENE HAPTEN AT 277K,SPB,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID
1FM6,HT,retinoic acid receptor rxr-alpha,2.1,X-Ray,THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.,9CR; BRL,"(9CIS)-RETINOIC ACID; 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2-(METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-(9CL)"
1FM9,HT,retinoic acid receptor rxr-alpha,2.1,X-Ray,THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.,9CR; 570,(9CIS)-RETINOIC ACID; 2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID
1FQ5,HT,saccharopepsin,2.4,X-Ray,"X-ray struture of a cyclic statine inhibitor PD-129,541 bound to yeast proteinase A",0GM; BMA; NAG; NDG; MAN,"N-[(5S,9S,10S,13S)-9-HYDROXY-5,10-BIS(2-METHYLPROPYL)-4,7,12,16-TETRAOXO-3,6,11,17-TETRAAZABICYCLO[17.3.1]TRICOSA-1(23),19,21-TRIEN-13-YL]-3-(NAPHTHALEN-1-YL)-2-(NAPHTHALEN-1-YLMETHYL)PROPANAMIDE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE; ALPHA-D-MANNOSE"
1FRP,HT,"fructose 1,6-bisphosphatase",2,X-Ray,"CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH FRUCTOSE-2,6-BISPHOSPHATE, AMP AND ZN2+ AT 2.0 ANGSTROMS RESOLUTION. ASPECTS OF SYNERGISM BETWEEN INHIBITORS",FDP; ZN; AMP,"FRUCTOSE-2,6-DIPHOSPHATE; ZINC ION; ADENOSINE MONOPHOSPHATE"
1FVT,HT,cell division protein kinase 2,2.2,X-Ray,THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR,106,4-(5-BROMO-2-OXO-2H-INDOL-3-YLAZO)-BENZENESULFONAMIDE
1G9V,HT,hemoglobin alpha chain,1.85,X-Ray,HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXY HEMOGLOBIN COMPLEXED WITH A POTENT ALLOSTERIC EFFECTOR,RQ3; SO4; HEM,"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID; SULFATE ION; PROTOPORPHYRIN IX CONTAINING FE"
1GM8,HT,penicillin g acylase alpha subunit,2,X-Ray,Crystal structures of penicillin acylase enzyme-substrate complexes: Structural insights into the catalytic mechanism,CA; SOX,"CALCIUM ION; N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE"
1GWX,HT,protein (ppar-delta),2.5,X-Ray,MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS,433,"2-(4-{3-[1-[2-(2-CHLORO-6-FLUORO-PHENYL)-ETHYL]-3-(2,3-DICHLORO-PHENYL)-UREIDO]-PROPYL}-PHENOXY)-2-METHYL-PROPIONIC ACID"
1H1P,HT,cell division protein kinase 2,2.1,X-Ray,STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058,CMG; TPO,6-O-CYCLOHEXYLMETHYL GUANINE; PHOSPHOTHREONINE
1H1S,HT,cell division protein kinase 2,2,X-Ray,STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102,4SP; TPO,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO)PURINE; PHOSPHOTHREONINE
1HDY,HT,alcohol dehydrogenase,2.5,X-Ray,THREE-DIMENSIONAL STRUCTURES OF THREE HUMAN ALCOHOL DEHYDROGENASE VARIANTS: CORRELATIONS WITH THEIR FUNCTIONAL DIFFERENCES,PYZ; ZN; CL; NAD,4-IODOPYRAZOLE; ZINC ION; CHLORIDE ION; NICOTINAMIDE-ADENINE-DINUCLEOTIDE
1HGG,HT,"hemagglutinin, chain ha1",2.9,X-Ray,"BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY",BGC; BMA; NAG; SIA; GAL,BETA-D-GLUCOSE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; O-SIALIC ACID; BETA-D-GALACTOSE
1HGH,HT,"hemagglutinin, chain ha1",2.7,X-Ray,"BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY",BMA; NAG; MNA,BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID
1HGI,HT,"hemagglutinin, chain ha1",2.7,X-Ray,"BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY",ANA; BMA; NAG,4-O-ACETYL-ALPHA-2-OMETHYL-5-N-ACETYL-ALPHA-D-NEURAMINIC ACID; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE
1HGJ,HT,"hemagglutinin, chain ha1",2.7,X-Ray,"BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY",BMA; NAG; AMN,BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; 9-DEOXY-9-AMINO-2-O-METHYL-5-N-ACETYL-ALPHA-D-NEURAMINIC ACID
1HNN,HT,phenylethanolamine n-methyltransferase,2.4,X-Ray,CRYSTAL STRUCTURE OF HUMAN PNMT COMPLEXED WITH SK&F 29661 AND ADOHCY(SAH),SAH; SKF,"S-ADENOSYL-L-HOMOCYSTEINE; 1,2,3,4-TETRAHYDRO-ISOQUINOLINE-7-SULFONIC ACID AMIDE"
1HP0,HT,inosine-adenosine-guanosine-preferring nucleoside hydrolase,2.1,X-Ray,CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX IN COMPLEX WITH THE SUBSTRATE ANALOGUE 3-DEAZA-ADENOSINE,CA; AD3,CALCIUM ION; 3-DEAZA-ADENOSINE
1HQ2,HT,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",1.25,X-Ray,"CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF E.COLI HPPK(R82A) WITH MGAMPCPP AND 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN AT 1.25 ANGSTROM RESOLUTION",APC; MG; CL; PH2; ACT,"DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER; MAGNESIUM ION; CHLORIDE ION; 2-AMINO-6-HYDROXYMETHYL-7,8-DIHYDRO-3H-PTERIDIN-4-ONE; ACETATE ION"
1HVY,HT,thymidylate synthase,1.9,X-Ray,"Human thymidylate synthase complexed with dUMP and Raltitrexed, an antifolate drug, is in the closed conformation",D16; CME; UMP; BME,"TOMUDEX; S,S-(2-HYDROXYETHYL)THIOCYSTEINE; 2'-DEOXYURIDINE 5'-MONOPHOSPHATE; BETA-MERCAPTOETHANOL"
1HWI,HT,hmg-coa reductase,2.3,X-Ray,COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH FLUVASTATIN,115; ADP,"7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID; ADENOSINE-5'-DIPHOSPHATE"
1HWW,HT,alpha-mannosidase ii,1.87,X-Ray,GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH SWAINSONINE,NAG; MRD; ZN; SWA,"N-ACETYL-D-GLUCOSAMINE; (4R)-2-METHYLPENTANE-2,4-DIOL; ZINC ION; 1S-8AB-OCTAHYDRO-INDOLIZIDINE-1A,2A,8B-TRIOL"
1IVB,HT,influenza virus b/lee/40 neuraminidase,2.4,X-Ray,STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE,NAG; CA; ST1,N-ACETYL-D-GLUCOSAMINE; CALCIUM ION; 4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID
1IVD,HT,influenza a subtype n2 neuraminidase,1.9,X-Ray,STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE,CA; FUC; BMA; NAG; FUL; ST1; MAN,CALCIUM ION; ALPHA-L-FUCOSE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; BETA-L-FUCOSE; 4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID; ALPHA-D-MANNOSE
1IVE,HT,influenza a subtype n2 neuraminidase,2.4,X-Ray,STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE,CA; NDG; ST3; FUC; BMA; NAG; FUL; MAN,CALCIUM ION; 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE; 4-(ACETYLAMINO)-3-AMINO BENZOIC ACID; ALPHA-L-FUCOSE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; BETA-L-FUCOSE; ALPHA-D-MANNOSE
1IVF,HT,influenza a subtype n2 neuraminidase,2.4,X-Ray,STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE,DAN; CA; FUC; BMA; NAG; FUL; MAN,"2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID; CALCIUM ION; ALPHA-L-FUCOSE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; BETA-L-FUCOSE; ALPHA-D-MANNOSE"
1IY7,HT,carboxypeptidase a,2,X-Ray,Crystal Structure of CPA and sulfamide-based inhibitor complex,ZN; CXA,ZINC ION; PHENYLALANINE-N-SULFONAMIDE
1JD0,HT,carbonic anhydrase xii,1.5,X-Ray,CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CARBONIC ANHYDRASE XII COMPLEXED WITH ACETAZOLAMIDE,AZM; ZN,"5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE; ZINC ION"
1JLA,HT,hiv-1 rt a-chain,2.5,X-Ray,CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651,CSD; TNK,3-SULFINOALANINE; 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL
1K1J,HT,trypsin,2.2,X-Ray,BOVINE TRYPSIN-INHIBITOR COMPLEX,FD2; CA; SO4,N-ALPHA-(2-NAPHTHYLSULFONYL)-N(3-AMIDINO-L-PHENYLALANINYL)ISOPIPECOLINIC ACID METHYL ESTER; CALCIUM ION; SULFATE ION
1K3U,HT,tryptophan synthase alpha chain,1.7,X-Ray,CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID,PLP; NA; IAD,PYRIDOXAL-5'-PHOSPHATE; SODIUM ION; N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID
1KE5,HT,cell division protein kinase 2,2.2,X-Ray,"CDK2 complexed with N-methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide",LS1,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE"
1L2S,HT,beta-lactamase,1.94,X-Ray,X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a DOCK-predicted non-covalent inhibitor,STC,3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLICACID
1L7F,HT,neuraminidase,1.8,X-Ray,Crystal structure of influenza virus neuraminidase in complex with BCX-1812,CA; BMA; NAG; GOL; BCZ; MAN,CALCIUM ION; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; GLYCEROL; 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)-4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; ALPHA-D-MANNOSE
1LPZ,HT,blood coagulation factor xa,2.4,X-Ray,CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.,CA; CMB,"CALCIUM ION; 1-(3-CARBAMIMIDOYLBENZYL)-N-(3,5-DICHLOROBENZYL)-4-METHYL-1H-INDOLE-2-CARBOXAMIDE"
1LQD,HT,blood coagulation factor xa,2.7,X-Ray,CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.,CMI; CA,"1-(3-CARBAMIMIDOYL-BENZYL)-4-METHYL-1H-INDOLE-2-CARBOXYLIC ACID 3,5-DIMETHYL-BENZYLAMIDE; CALCIUM ION"
1LRH,HT,auxin-binding protein 1,1.9,X-Ray,Crystal structure of auxin-binding protein 1 in complex with 1-naphthalene acetic acid,BMA; NAG; NLA; ZN; MAN,BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; NAPHTHALEN-1-YL-ACETIC ACID; ZINC ION; ALPHA-D-MANNOSE
1M2Z,HT,glucocorticoid receptor,2.5,X-Ray,Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a TIF2 coactivator motif,BOG; DEX,B-OCTYLGLUCOSIDE; DEXAMETHASONE
1MBI,HT,myoglobin,2,X-Ray,X-RAY CRYSTAL STRUCTURE OF THE FERRIC SPERM WHALE MYOGLOBIN: IMIDAZOLE COMPLEX AT 2.0 ANGSTROMS RESOLUTION,SO4; HEM; IMD,SULFATE ION; PROTOPORPHYRIN IX CONTAINING FE; IMIDAZOLE
1ML1,HT,triosephosphate isomerase,2.6,X-Ray,PROTEIN ENGINEERING WITH MONOMERIC TRIOSEPHOSPHATE ISOMERASE: THE MODELLING AND STRUCTURE VERIFICATION OF A SEVEN RESIDUE LOOP,PGA,2-PHOSPHOGLYCOLIC ACID
1MMV,HT,"nitric-oxide synthase, brain",2,X-Ray,Rat neuronal NOS heme domain with NG-propyl-L-arginine bound,ACT; H4B; ZN; HEM; 3AR,"ACETATE ION; 5,6,7,8-TETRAHYDROBIOPTERIN; ZINC ION; PROTOPORPHYRIN IX CONTAINING FE; N-OMEGA-PROPYL-L-ARGININE"
1MQ6,HT,coagulation factor x heavy chain,2.1,X-Ray,"Crystal Structure of 3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa",CA; XLD; GOL,"CALCIUM ION; 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL)AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL)METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE; GLYCEROL"
1MTS,HT,trypsin,1.9,X-Ray,FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN,BX3; CA,(+)-2-[4-[(-1-ACETIMIDOYL-4-PIPERIDINYL)OXY]-3-(7-AMIDINO-2-NAPHTHYL)PROPIONIC ACID; CALCIUM ION
1MZC,HT,protein farnesyltransferase alpha subunit,2,X-Ray,Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a,FPP; ZN; SUC; BNE,FARNESYL DIPHOSPHATE; ZINC ION; SUCROSE; 2-[3-(3-ETHYL-1-METHYL-2-OXO-AZEPAN-3-YL)-PHENOXY]-4-[1-AMINO-1-(1-METHYL-1H-IMIDIZOL-5-YL)-ETHYL]-BENZONITRILE
1N1M,HT,dipeptidyl peptidase iv soluble form,2.5,X-Ray,Human Dipeptidyl Peptidase IV/CD26 in complex with an inhibitor,HG; NDG; FUC; BMA; NAG; A3M; MAN,MERCURY (II) ION; 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE; ALPHA-L-FUCOSE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; 2-AMINO-3-METHYL-1-PYRROLIDIN-1-YL-BUTAN-1-ONE; ALPHA-D-MANNOSE
1N2J,HT,pantothenate synthetase,1.8,X-Ray,Crystal Structure of a Pantothenate Synthetase from M. tuberculosis in complex with pantoate,PAF; GOL; EOH; SO4; BAL,PANTOATE; GLYCEROL; ETHANOL; SULFATE ION; BETA-ALANINE
1N2V,HT,queuine trna-ribosyltransferase,2.1,X-Ray,"Crystal Structure of TGT in complex with 2-Butyl-5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione",ZN; BDI,"ZINC ION; 2-BUTYL-5,6-DIHYDRO-1H-IMIDAZO[4,5-D]PYRIDAZINE-4,7-DIONE"
1NAV,HT,"hormone receptor alpha 1, thra1",2.5,X-Ray,Thyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1,SO4; IH5,"SULFATE ION; {3,5-DICHLORO-4-[4-HYDROXY-3-(PROPAN-2-YL)PHENOXY]PHENYL}ACETIC ACID"
1OF1,HT,thymidine kinase,1.95,X-Ray,KINETICS AND CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE INTERACTING WITH (SOUTH)-METHANOCARBA-THYMIDINE,SO4; SCT,SULFATE ION; (SOUTH)-METHANOCARBA-THYMIDINE
1OF6,HT,"phospho-2-dehydro-3-deoxyheptonate aldolase, tyrosine-inhibited",2.1,X-Ray,crystal structure of the tyrosine-regulated 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase from saccharomyces cerevisiae complexed with tyrosine and manganese,MN; DTY,MANGANESE (II) ION; D-TYROSINE
1OQ5,HT,carbonic anhydrase ii,1.5,X-Ray,CARBONIC ANHYDRASE II IN COMPLEX WITH NANOMOLAR INHIBITOR,ZN; CEL,ZINC ION; 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
1OWE,HT,urokinase-type plasminogen activator,1.6,X-Ray,Substituted 2-Naphthamidine inhibitors of urokinase,675; SO4,6-[(Z)-AMINO(IMINO)METHYL]-N-PHENYL-2-NAPHTHAMIDE; SULFATE ION
1OYT,HT,thrombin light chain,1.67,X-Ray,COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR,FSN; NA; CA; SIN,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE; SODIUM ION; CALCIUM ION; SUCCINIC ACID"
1P2Y,HT,cytochrome p450-cam,2.3,X-Ray,CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)-(-)-NICOTINE,NCT; HEM,(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE; PROTOPORPHYRIN IX CONTAINING FE
1P62,HT,deoxycytidine kinase,1.9,X-Ray,Structure of human dCK complexed with gemcitabine and ADP-MG,MG; GEO; ADP,MAGNESIUM ION; GEMCITABINE; ADENOSINE-5'-DIPHOSPHATE
1PBD,HT,p-hydroxybenzoate hydroxylase,2.3,X-Ray,"CRYSTAL STRUCTURES OF WILD-TYPE P-HYDROXYBENZOATE HYDROXYLASE COMPLEXED WITH 4-AMINOBENZOATE, 2,4-DIHYDROXYBENZOATE AND 2-HYDROXY-4-AMINOBENZOATE AND OF THE TRY222ALA MUTANT, COMPLEXED WITH 2-HYDROXY-4-AMINOBENZOATE. EVIDENCE FOR A PROTON CHANNEL AND A NEW BINDING MODE OF THE FLAVIN RING",FAD; PAB,FLAVIN-ADENINE DINUCLEOTIDE; 4-AMINOBENZOIC ACID
1PMN,HT,mitogen-activated protein kinase 10,2.2,X-Ray,Crystal structure of JNK3 in complex with an imidazole-pyrimidine inhibitor,984,"CYCLOPROPYL-{4-[5-(3,4-DICHLOROPHENYL)-2-[(1-METHYL)-PIPERIDIN]-4-YL-3-PROPYL-3H-IMIDAZOL-4-YL]-PYRIMIDIN-2-YL}AMINE"
1PSO,HT,pepsin 3a,2,X-Ray,The crystal structure of human pepsin and its complex with pepstatin,IVA; STA,ISOVALERIC ACID; STATINE
1Q1G,HT,uridine phosphorylase putative,2.02,X-Ray,Crystal structure of Plasmodium falciparum PNP with 5'-methylthio-immucillin-H,IPA; SO4; MTI,"ISOPROPYL ALCOHOL; SULFATE ION; 3,4-DIHYDROXY-2-[(METHYLSULFANYL)METHYL]-5-(4-OXO-4,5-DIHYDRO-3H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)PYRROLIDINIUM"
1Q41,HT,glycogen synthase kinase-3 beta,2.1,X-Ray,GSK-3 Beta complexed with Indirubin-3'-monoxime,IXM,"(Z)-1H,1'H-[2,3']BIINDOLYLIDENE-3,2'-DIONE-3-OXIME"
1QHI,HT,protein (thymidine kinase),1.9,X-Ray,"HERPES SIMPLEX VIRUS TYPE-I THYMIDINE KINASE COMPLEXED WITH A NOVEL NON-SUBSTRATE INHIBITOR, 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE",SO4; BPG,SULFATE ION; 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE
1R58,HT,methionine aminopeptidase 2,1.9,X-Ray,Crystal Structure of MetAP2 complexed with A357300,MN; AO5,"MANGANESE (II) ION; N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE"
1R9O,HT,cytochrome p450 2c9,2,X-Ray,Crystal Structure of P4502C9 with Flurbiprofen bound,FLP; HEM; GOL,FLURBIPROFEN; PROTOPORPHYRIN IX CONTAINING FE; GLYCEROL
1ROB,HT,ribonuclease a,1.6,X-Ray,STRUCTURE OF THE CRYSTALLINE COMPLEX OF CYTIDYLIC ACID (2'-CMP) WITH RIBONUCLEASE AT 1.6 ANGSTROMS RESOLUTION,C2P,CYTIDINE-2'-MONOPHOSPHATE
1S19,HT,vitamin d3 receptor,2.1,X-Ray,Crystal structure of VDR ligand binding domain complexed to calcipotriol.,MC9,CALCIPOTRIOL
1SQ5,HT,pantothenate kinase,2.2,X-Ray,Crystal Structure of E. coli Pantothenate kinase,PAU; ADP,PANTOTHENOIC ACID; ADENOSINE-5'-DIPHOSPHATE
1TOW,HT,"fatty acid-binding protein, adipocyte",2,X-Ray,Crystal structure of human adipocyte fatty acid binding protein in complex with a carboxylic acid ligand,CRZ,4-(9H-CARBAZOL-9-YL)BUTANOIC ACID
1TT1,HT,"glutamate receptor, ionotropic kainate 2",1.93,X-Ray,CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH KAINATE 1.93 A RESOLUTION,KAI,3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE
1U4D,HT,activated cdc42 kinase 1,2.1,X-Ray,Structure of the ACK1 Kinase Domain bound to Debromohymenialdisine,CL; DBQ,CHLORIDE ION; DEBROMOHYMENIALDISINE
1UKZ,HT,uridylate kinase,1.9,X-Ray,SUBSTRATE SPECIFICITY AND ASSEMBLY OF CATALYTIC CENTER DERIVED FROM TWO STRUCTURES OF LIGATED URIDYLATE KINASE,ADP; AMP,ADENOSINE-5'-DIPHOSPHATE; ADENOSINE MONOPHOSPHATE
1ULB,HT,purine nucleoside phosphorylase,2.75,X-Ray,APPLICATION OF CRYSTALLOGRAPHIC AND MODELING METHODS IN THE DESIGN OF PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITORS,SO4; GUN,SULFATE ION; GUANINE
1UML,HT,adenosine deaminase,2.5,X-Ray,Crystal structure of adenosine deaminase complexed with a potent inhibitor FR233624,FR4; ZN,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE; ZINC ION
1UNL,HT,cyclin-dependent kinase 5,2.2,X-Ray,"STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.",RRC,R-ROSCOVITINE
1UOU,HT,thymidine phosphorylase,2.11,X-Ray,CRYSTAL STRUCTURE OF HUMAN THYMIDINE PHOSPHORYLASE IN COMPLEX WITH A SMALL MOLECULE INHIBITOR,CMU,5-CHLORO-6-(1-(2-IMINOPYRROLIDINYL) METHYL)URACIL
1V0P,HT,cell division control protein 2 homolog,2,X-Ray,STRUCTURE OF P. FALCIPARUM PFPK5-PURVALANOL B LIGAND COMPLEX,PVB,PURVALANOL B
1W1P,HT,chitinase b,2.1,X-Ray,CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE B IN COMPLEX WITH THE CYCLIC DIPEPTIDE INHIBITOR CYCLO-(GLY-L-PRO) AT 2.1 A RESOLUTION,GIO; SO4; GOL,CYCLO-(GLYCINE-L-PROLINE) INHIBITOR; SULFATE ION; GLYCEROL
1W2G,HT,thymidylate kinase tmk,2.1,X-Ray,CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS THYMIDYLATE KINASE COMPLEXED WITH DEOXYTHYMIDINE (DT) (2.1 A RESOLUTION),ACT; THM,ACETATE ION; THYMIDINE
1X8X,HT,tyrosyl-trna synthetase,2,X-Ray,Tyrosyl t-RNA Synthetase from E.coli Complexed with Tyrosine,TYR; SO4,TYROSINE; SULFATE ION
1XM6,HT,"camp-specific 3',5'-cyclic phosphodiesterase 4b",1.92,X-Ray,Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Mesopram,CME; ZN; MG; 5RM,"S,S-(2-HYDROXYETHYL)THIOCYSTEINE; ZINC ION; MAGNESIUM ION; (5R)-5-(4-METHOXY-3-PROPOXYPHENYL)-5-METHYL-1,3-OXAZOLIDIN-2-ONE"
1XOQ,HT,"camp-specific 3',5'-cyclic phosphodiesterase 4d",1.83,X-Ray,Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Roflumilast,EDO; ZN; MG; ROF,"1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE"
1YDR,HT,c-amp-dependent protein kinase,2.2,X-Ray,"STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE",SEP; IQP; TPO,PHOSPHOSERINE; 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; PHOSPHOTHREONINE
1YDS,HT,c-amp-dependent protein kinase,2.2,X-Ray,"Structure of CAMP-dependent protein kinase, alpha-catalytic subunit in complex with H8 protein kinase inhibitor [N-(2-methylamino)ethyl]-5-isoquinolinesulfonamide",SEP; IQS; TPO,PHOSPHOSERINE; N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE; PHOSPHOTHREONINE
1YDT,HT,c-amp-dependent protein kinase,2.3,X-Ray,"STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE",SEP; IQB; TPO,PHOSPHOSERINE; N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE; PHOSPHOTHREONINE
1YQY,HT,lethal factor,2.3,X-Ray,Structure of B. Anthrax Lethal factor in complex with a hydroxamate inhibitor,ZN; 915,ZINC ION; (2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE
1YV3,HT,myosin ii heavy chain,2,X-Ray,The structural basis of blebbistatin inhibition and specificity for myosin II,ADP; EDO; MG; VO4; BIT,"ADENOSINE-5'-DIPHOSPHATE; 1,2-ETHANEDIOL; MAGNESIUM ION; VANADATE ION; (-)-1-PHENYL-1,2,3,4-TETRAHYDRO-4-HYDROXYPYRROLO[2,3-B]-7-METHYLQUINOLIN-4-ONE"
1YVF,HT,hcv ns5b polymerase,2.5,X-Ray,Hepatitis C virus NS5B RNA-dependent RNA polymerase complex with inhibitor PHA-00729145,PH7; CL; PO4; GOL,(2Z)-2-(BENZOYLAMINO)-3-[4-(2-BROMOPHENOXY)PHENYL]-2-PROPENOIC ACID; CHLORIDE ION; PHOSPHATE ION; GLYCEROL
1YWR,HT,mitogen-activated protein kinase 14,1.95,X-Ray,Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor,LI9,"4-(4-FLUOROPHENYL)-1-METHYL-5-(2-{[(1S)-1-PHENYLETHYL]AMINO}PYRIMIDIN-4-YL)-2-PIPERIDIN-4-YL-1,2-DIHYDRO-3H-PYRAZOL-3-ONE"
2ACK,HT,acetylcholinesterase,2.4,X-Ray,"ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA",EDR,EDROPHONIUM ION
2BR1,HT,serine/threonine-protein kinase chk1,2,X-Ray,STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY,SO4; PFP,"SULFATE ION; 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL"
2CTC,HT,carboxypeptidase a,1.4,X-Ray,THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CARBOXYPEPTIDASE A AND L-PHENYL LACTATE,ZN; HFA,ZINC ION; ALPHA-HYDROXY-BETA-PHENYL-PROPIONIC ACID
2MCP,HT,iga-kappa mcpc603 fab (light chain),3.1,X-Ray,REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION,PC,PHOSPHOCHOLINE
2PCP,HT,immunoglobulin,2.2,X-Ray,ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE,1PC,1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE
2TMN,HT,thermolysin,1.6,X-Ray,CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN,ZN; CA; 0FA,ZINC ION; CALCIUM ION; N~2~-PHOSPHONO-L-LEUCINAMIDE
3PTB,HT,beta-trypsin,1.7,X-Ray,"THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS",CA; BEN,CALCIUM ION; BENZAMIDINE
4AAH,HT,methanol dehydrogenase,2.4,X-Ray,METHANOL DEHYDROGENASE FROM METHYLOPHILUS W3A1,CA; PQQ,CALCIUM ION; PYRROLOQUINOLINE QUINONE
4COX,HT,cyclooxygenase-2,2.9,X-Ray,"CYCLOOXYGENASE-2 (PROSTAGLANDIN SYNTHASE-2) COMPLEXED WITH A NON-SELECTIVE INHIBITOR, INDOMETHACIN",NAG; IMN; HEM,N-ACETYL-D-GLUCOSAMINE; INDOMETHACIN; PROTOPORPHYRIN IX CONTAINING FE
4TS1,MT,tyrosyl-trna synthetase,2.5,X-Ray,CRYSTAL STRUCTURE OF A DELETION MUTANT OF A TYROSYL-T/RNA SYNTHETASE COMPLEXED WITH TYROSINE,TYR,TYROSINE
13GS,MT,glutathione s-transferase,1.9,X-Ray,GLUTATHIONE S-TRANSFERASE COMPLEXED WITH SULFASALAZINE,GSH; MES; SAS,GLUTATHIONE; 2-(N-MORPHOLINO)-ETHANESULFONIC ACID; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
1A07,MT,c-src tyrosine kinase,2.2,X-Ray,"C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE)",ACE; DIP; PTR,ACETYL GROUP; DIPENTYLAMINE; O-PHOSPHOTYROSINE
1A1B,MT,c-src tyrosine kinase,2.2,X-Ray,"C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)",ACE; DIP; PTR,ACETYL GROUP; DIPENTYLAMINE; O-PHOSPHOTYROSINE
1A1E,MT,c-src tyrosine kinase,2.2,X-Ray,C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3-BUTYLPIPERIDINE),ACE; DIY; PTR,ACETYL GROUP; 5-BUTYLPIPERIDINE; O-PHOSPHOTYROSINE
1A4K,MT,antibody fab,2.4,X-Ray,DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE,CD; FRA,"CADMIUM ION; [4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETICACID"
1A8T,MT,metallo-beta-lactamase,2.55,X-Ray,"METALLO-BETA-LACTAMASE IN COMPLEX WITH L-159,061",061; ZN,2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE; ZINC ION
1AFQ,MT,bovine gamma-chymotrypsin,1.8,X-Ray,CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR,0FG; SO4,D-LEUCYL-N-(4-FLUOROBENZYL)-L-PHENYLALANINAMIDE; SULFATE ION
1AKE,MT,adenylate kinase,2,X-Ray,STRUCTURE OF THE COMPLEX BETWEEN ADENYLATE KINASE FROM ESCHERICHIA COLI AND THE INHIBITOR AP5A REFINED AT 1.9 ANGSTROMS RESOLUTION: A MODEL FOR A CATALYTIC TRANSITION STATE,AP5,BIS(ADENOSINE)-5'-PENTAPHOSPHATE
1AVD,MT,avidin,2.7,X-Ray,THREE-DIMENSIONAL STRUCTURE OF THE TETRAGONAL CRYSTAL FORM OF EGG-WHITE AVIDIN IN ITS FUNCTIONAL COMPLEX WITH BIOTIN AT 2.7 ANGSTROMS RESOLUTION,BTN; NAG,BIOTIN; N-ACETYL-D-GLUCOSAMINE
1B59,MT,protein (methionine aminopeptidase),1.8,X-Ray,COMPLEX OF HUMAN METHIONINE AMINOPEPTIDASE-2 COMPLEXED WITH OVALICIN,OVA; CO,"3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE; COBALT (II) ION"
1B6J,MT,retropepsin,1.85,X-Ray,HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1,ABA; NH2; RTY; SO4,"ALPHA-AMINOBUTYRIC ACID; AMINO GROUP; 4-{4-[(2S,3R)-2-AMINO-4-BROMO-3-HYDROXYBUTYL]PHENOXY}BUTANOIC ACID; SULFATE ION"
1B6K,MT,retropepsin,1.85,X-Ray,HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5,ABA; PI5; SO4,"ALPHA-AMINOBUTYRIC ACID; N-[3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2]HEPTADECA-1(16),13(17),14- TRIEN-11-YLAMINO)-2-HYDROXY-1-(4-HYDROXY-BENZYL)-PROPYL]-3-METHYL-2- (2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE; SULFATE ION"
1B6L,MT,retropepsin,1.75,X-Ray,HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4,ABA; PI4; SO4,"ALPHA-AMINOBUTYRIC ACID; 1-[2-(8-CARBAMOYLMETHYL-6,9-DIOXO-2-OXA-7,10-DIAZA-BICYCLO[11.2.2]HEPTADECA- 1(16),13(17),14-TRIEN-11-YL)-2-HYDROXY-ETHYL]-PIPERIDINE-2-CARBOXYLIC ACIDTERT-BUTYLAMIDE; SULFATE ION"
1B6M,MT,retropepsin,1.85,X-Ray,HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6,ABA; PI6; SO4,"ALPHA-AMINOBUTYRIC ACID; [1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA-1(16),13(17),14-TRIEN-11-YLAMINO)-2-HYDROXY-PROPYL]-CARBAMIC ACID TERT-BUTYLESTER; SULFATE ION"
1BKM,MT,pp60 v-src tyrosine kinase transforming protein,2,X-Ray,COCRYSTAL STRUCTURE OF D-AMINO ACID SUBSTITUTED PHOSPHOPEPTIDE COMPLEX,1C5,[[O-PHOSPHONO-N-ACETYL-TYROSINYL]-GLUTAMYL-3[CYCLOHEXYLMETHYL]ALANINYL]-AMINE
1BMQ,MT,protein (interleukin-1 beta convertase),2.5,X-Ray,"CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR, (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL }AMINO)-4-OXOBUTANAMIDE",MNO,(3S)-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL}AMINO)-4-OXOBUTANAMIDE
1C2T,MT,glycinamide ribonucleotide transformylase,2.1,X-Ray,"NEW INSIGHTS INTO INHIBITOR DESIGN FROM THE CRYSTAL STRUCTURE AND NMR STUDIES OF E. COLI GAR TRANSFORMYLASE IN COMPLEX WITH BETA-GAR AND 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID.",GAR; NHS,"GLYCINAMIDE RIBONUCLEOTIDE; 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID"
1C3I,MT,stromelysin-1,1.83,X-Ray,HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812,TR1; ZN; CA,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACIDMETHYL ESTER; ZINC ION; CALCIUM ION
1C5C,MT,chimeric decarboxylase antibody 21d8,1.61,X-Ray,DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX,TK4; GOL,"2-ACETYLAMINO-NAPTHALENE-1,5-DISULFONIC ACID; GLYCEROL"
1C5P,MT,protein (trypsin),1.43,X-Ray,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR",BAM; MG; CA; SO4,BENZAMIDINE; MAGNESIUM ION; CALCIUM ION; SULFATE ION
1C5X,MT,protein (urokinase-type plasminogen activator),1.75,X-Ray,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR",FLC; ESI,CITRATE ANION; 4-IODOBENZO[B]THIOPHENE-2-CARBOXAMIDINE
1CBS,MT,cellular retinoic acid binding protein type ii,1.8,X-Ray,CRYSTAL STRUCTURE OF CELLULAR RETINOIC-ACID-BINDING PROTEINS I AND II IN COMPLEX WITH ALL-TRANS-RETINOIC ACID AND A SYNTHETIC RETINOID,REA,RETINOIC ACID
1CDE,MT,phosphoribosyl-glycinamide formyltransferase,2.5,X-Ray,STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE,GAR; DZF,GLYCINAMIDE RIBONUCLEOTIDE; 5-DEAZAFOLIC ACID
1CDG,MT,cyclodextrin glycosyl-transferase,2,X-Ray,NUCLEOTIDE SEQUENCE AND X-RAY STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 IN A MALTOSE-DEPENDENT CRYSTAL FORM,CA; MAL,CALCIUM ION; MALTOSE
1CET,MT,protein (l-lactate dehydrogenase),2.05,X-Ray,CHLOROQUINE BINDS IN THE COFACTOR BINDING SITE OF PLASMODIUM FALCIPARUM LACTATE DEHYDROGENASE.,CLQ,"N4-(7-CHLORO-QUINOLIN-4-YL)-N1,N1-DIETHYL-PENTANE-1,4-DIAMINE"
1COY,MT,cholesterol oxidase,1.8,X-Ray,CRYSTAL STRUCTURE OF CHOLESTEROL OXIDASE COMPLEXED WITH A STEROID SUBSTRATE. IMPLICATIONS FOR FAD DEPENDENT ALCOHOL OXIDASES,FAD; AND,FLAVIN-ADENINE DINUCLEOTIDE; 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE
1CQP,MT,antigen cd11a (p180),2.6,X-Ray,CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION,MG; 803,MAGNESIUM ION; LOVASTATIN
1CTT,MT,cytidine deaminase,2.2,X-Ray,TRANSITION-STATE SELECTIVITY FOR A SINGLE OH GROUP DURING CATALYSIS BY CYTIDINE DEAMINASE,ZN; DHZ,"ZINC ION; 3,4-DIHYDRO-1H-PYRIMIDIN-2-ONE NUCLEOSIDE"
1D0L,MT,35kd soluble lytic transglycosylase,1.97,X-Ray,THE ESCHERICHIA COLI LYTIC TRANSGLYCOSYLASE SLT35 IN COMPLEX WITH BULGECIN A,BLG; CA,4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)-5-METHYLHYDROXY-L-PROLINE-TAURINE; CALCIUM ION
1DIB,MT,methylenetetrahydrofolate dehydrogenase/cyclohydrolase,2.7,X-Ray,HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE COMPLEXED WITH NADP AND INHIBITOR LY345899,NAP; L34,"NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE; 4-(7-AMINO-9-HYDROXY-1-OXO-3,3A,4,5-TETRAHYDRO-2,5,6,8,9B-PENTAAZA-CYCLOPENTA[A]NAPHTHALEN-2-YL)-PHENYLCARBONYL-GLUTAMIC ACID"
1DY9,MT,protease/helicase ns3 (p70),2.1,X-Ray,Inhibition of the Hepatitis C Virus NS3/4A Protease. The Crystal Structures of Two Protease-Inhibitor Complexes (inhibitor I),2ZF; ZN,"N-(TERT-BUTOXYCARBONYL)-L-ALPHA-GLUTAMYL-N-[(1R)-1-(CARBOXYCARBONYL)-3,3-DIFLUOROPROPYL]-L-LEUCINAMIDE; ZINC ION"
1EVE,MT,acetylcholinesterase,2.5,X-Ray,"THREE DIMENSIONAL STRUCTURE OF THE ANTI-ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE",NAG; E20,"N-ACETYL-D-GLUCOSAMINE; 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE"
1F0R,MT,coagulation factor xa,2.1,X-Ray,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815,815; CA,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE; CALCIUM ION"
1FBL,MT,fibroblast (interstitial) collagenase (mmp-1),2.5,X-Ray,"STRUCTURE OF FULL-LENGTH PORCINE SYNOVIAL COLLAGENASE (MMP1) REVEALS A C-TERMINAL DOMAIN CONTAINING A CALCIUM-LINKED, FOUR-BLADED BETA-PROPELLER",ZN; CA; HTA,ZINC ION; CALCIUM ION; N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE
1GKC,MT,92 kda type iv collagenase,2.3,X-Ray,MMP9-INHIBITOR COMPLEX,ZN; CA; NFH,"ZINC ION; CALCIUM ION; N~2~-[(2R)-2-{[FORMYL(HYDROXY)AMINO]METHYL}-4-METHYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE"
1GPK,MT,acetylcholinesterase,2.1,X-Ray,STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH (+)-HUPERZINE A AT 2.1A RESOLUTION,NAG; HUP,N-ACETYL-D-GLUCOSAMINE; HUPERZINE A
1GSP,MT,ribonuclease t1,2.2,X-Ray,"RIBONUCLEASE T1 COMPLEXED WITH 2',3'-CGPS, 1 DAY",SGP; CA,"GUANOSINE-2',3'-CYCLOPHOSPHOROTHIOATE; CALCIUM ION"
1HBV,MT,hiv-1 protease,2.3,X-Ray,A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC,GAN,"2-[3-BENZYL-5-(1-ALANYL-AMINOETHYL)-2,3,6,7-TETRAHYDRO-1H-AZEPIN-1-YL]-1-OXOPROPYL-VALINYL-VALINE-METHYLESTER"
1I7Z,MT,chimera of ig kappa chain: human constant region and mouse variable region,2.3,X-Ray,ANTIBODY GNC92H2 BOUND TO LIGAND,COC,COCAINE
1IA1,MT,dihydrofolate reductase,1.7,X-Ray,"Candida albicans dihydrofolate reductase complexed with dihydro-nicotinamide-adenine-dinucleotide phosphate (NADPH) and 5-(PHENYLSULFANYL)-2,4-QUINAZOLINEDIAMINE (GW997)",NDP; TQ3; PO4,"NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDEPHOSPHATE; 5-PHENYLSULFANYL-2,4-QUINAZOLINEDIAMINE; PHOSPHATE ION"
1IBG,MT,igg2b-kappa 40-50 fab (light chain),2.7,X-Ray,STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50,OBN; CU,OUABAIN; COPPER (II) ION
1ICN,MT,intestinal fatty acid binding protein,1.74,X-Ray,ESCHERICHIA COLI-DERIVED RAT INTESTINAL FATTY ACID BINDING PROTEIN WITH BOUND MYRISTATE AT 1.5 A RESOLUTION AND I-FABPARG106-->GLN WITH BOUND OLEATE AT 1.74 A RESOLUTION,OLA,OLEIC ACID
1IG3,MT,thiamin pyrophosphokinase,1.9,X-Ray,Mouse Thiamin Pyrophosphokinase Complexed with Thiamin,SO4; VIB,SULFATE ION; 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM
1IGJ,MT,igg2a-kappa 26-10 fab (light chain),2.5,X-Ray,26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY,DGX,DIGOXIN
1IVC,MT,influenza a subtype n2 neuraminidase,2.4,X-Ray,STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE,CA; ST2; FUC; BMA; NAG; FUL; MAN,CALCIUM ION; 4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID; ALPHA-L-FUCOSE; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; BETA-L-FUCOSE; ALPHA-D-MANNOSE
1J3J,MT,bifunctional dihydrofolate reductase-thymidylate synthase,2.3,X-Ray,"Double mutant (C59R+S108N) Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS) complexed with pyrimethamine, NADPH, and dUMP",NDP; UMP; CP6,"NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDEPHOSPHATE; 2'-DEOXYURIDINE 5'-MONOPHOSPHATE; 5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE"
1JJE,MT,imp-1 metallo beta-lactamase,1.8,X-Ray,IMP-1 METALLO BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH A BIARYL SUCCINIC ACID INHIBITOR (11),ZN; ACT; BYS,"ZINC ION; ACETATE ION; 2-BENZO[1,3]DIOXOL-5-YLMETHYL-3-BENZYL-SUCCINIC ACID"
1K7E,MT,tryptophan synthase alpha chain,2.3,X-Ray,CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,PLP; NA; IAG,PYRIDOXAL-5'-PHOSPHATE; SODIUM ION; N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID
1K7F,MT,tryptophan synthase alpha chain,1.9,X-Ray,CRYSTAL STRUCTURE OF WILD-TYPE TRYPTOPHAN SYNTHASE COMPLEXED WITH N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,IAV; PLP,N-[1H-INDOL-3-YL-ACETYL]VALINE ACID; PYRIDOXAL-5'-PHOSPHATE
1KEL,MT,28b4 fab,1.9,X-Ray,CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID),AAH,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID
1KZK,MT,protease,1.09,X-Ray,JE-2147-HIV Protease Complex,EDO; JE2; CL,"1,2-ETHANEDIOL; (4R)-3-{(2S,3S)-2-HYDROXY-3-[(3-HYDROXY-2-METHYLBENZOYL)AMINO]-4-PHENYLBUTANOYL}-5,5-DIMETHYL-N-(2-METHYLBENZYL)-1,3-THIAZOLIDINE-4-CARBOXAMIDE; CHLORIDE ION"
1LMO,MT,lysozyme,1.8,X-Ray,THE CRYSTAL STRUCTURES OF THREE COMPLEXES BETWEEN CHITOOLIGOSACCHARIDES AND LYSOZYME FROM THE RAINBOW TROUT,NAG,N-ACETYL-D-GLUCOSAMINE
1LPM,MT,lipase,2.18,X-Ray,A STRUCTURAL BASIS FOR THE CHIRAL PREFERENCES OF LIPASES,NAG; CA; MPA,N-ACETYL-D-GLUCOSAMINE; CALCIUM ION; (1R)-MENTHYL HEXYL PHOSPHONATE GROUP
1LYL,MT,lysyl-trna synthetase (lysu),2.8,X-Ray,LYSYL-TRNA SYNTHETASE (LYSU) (E.C.6.1.1.6) COMPLEXED WITH LYSINE,LYS,LYSINE
1M48,MT,interleukin-2,1.95,X-Ray,Crystal Structure of Human IL-2 Complexed with (R)-N-[2-[1-(Aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-L-phenylalanine methyl ester,FRG,2-[3-METHYL-4-(N-METHYL-GUANIDINO)-BUTYRYLAMINO]-3-(4-PHENYLETHYNYL-PHENYL)-PROPIONIC ACID METHYL ESTER
1MEH,MT,inosine-5'-monophosphate dehydrogenase,1.95,X-Ray,Inosine Monophosphate Dehydrogenase (IMPDH) From Tritrichomonas Foetus with IMP and MOA bound,CSO; IMP; MOA; POTASSIUM,S-HYDROXYCYSTEINE; INOSINIC ACID; MYCOPHENOLIC ACID; ION
1MQ5,MT,coagulation factor x heavy chain,2.1,X-Ray,Crystal Structure of 3-chloro-N-[4-chloro-2-[[(4-chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-2-thiophenecarboxamide Complexed with Human Factor Xa,XLC; CA; GOL,3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL)AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE; CALCIUM ION; GLYCEROL
1MRG,MT,alpha-momorcharin,1.8,X-Ray,STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS,ADN,ADENOSINE
1MRK,MT,alpha-trichosanthin,1.6,X-Ray,STUDIES ON CRYSTAL STRUCTURES ACTIVE CENTER GEOMETRY AND DEPURINE MECHANISM OF TWO RIBOSOME-INACTIVATING PROTEINS,FMC,FORMYCIN
1MTW,MT,trypsin,1.9,X-Ray,FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN,CA; DX9,CALCIUM ION; (2S)-3-(7-CARBAMIMIDOYLNAPHTHALEN-2-YL)-2-[4-({(3R)-1-[(1Z)-ETHANIMIDOYL]PYRROLIDIN-3-YL}OXY)PHENYL]PROPANOIC ACID
1N46,MT,thyroid hormone receptor beta-1,2.2,X-Ray,CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC,PFA,"[4-(4-HYDROXY-3-ISOPROPYL-PHENOXY)-3,5-DIMETHYL-PHENYL]-6-AZAURACIL"
1NHU,MT,hepatitis c virus ns5b rna-dependent rna polymerase,2,X-Ray,Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor,153,"(2S)-2-[(2,4-DICHLORO-BENZOYL)-(3-TRIFLUOROMETHYL-BENZYL)-AMINO]-3-PHENYL-PROPIONIC ACID"
1NHV,MT,hepatitis c virus ns5b rna-dependent rna polymerase,2.9,X-Ray,Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor,154,"(2S)-2-[(5-BENZOFURAN-2-YL-THIOPHEN-2-YLMETHYL)-(2,4-DICHLORO-BENZOYL)-AMINO]-3-PHENYL-PROPIONIC ACID"
1ODW,MT,hiv-1 protease,2.1,X-Ray,Native HIV-1 Proteinase,0E+00,"DI-TERT-BUTYL {IMINOBIS[(2S,3S)-3-HYDROXY-1-PHENYLBUTANE-4,2-DIYL]}BISCARBAMATE"
1OPK,MT,proto-oncogene tyrosine-protein kinase abl1,1.8,X-Ray,Structural basis for the auto-inhibition of c-Abl tyrosine kinase,MYR; P16; GOL,"MYRISTIC ACID; 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE; GLYCEROL"
1PGP,MT,6-phosphogluconate dehydrogenase,2.5,X-Ray,"CRYSTALLOGRAPHIC STUDY OF COENZYME, COENZYME ANALOGUE AND SUBSTRATE BINDING IN 6-PHOSPHOGLUCONATE DEHYDROGENASE: IMPLICATIONS FOR NADP SPECIFICITY AND THE ENZYME MECHANISM",6PG; SO4,6-PHOSPHOGLUCONIC ACID; SULFATE ION
1Q4G,MT,prostaglandin g/h synthase 1,2,X-Ray,"2.0 Angstrom Crystal Structure of Ovine Prostaglandin H2 Synthase-1, in complex with alpha-methyl-4-biphenylacetic acid",BOG; NDG; GOL; BMA; NAG; BFL; HEM; MAN,"B-OCTYLGLUCOSIDE; 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE; GLYCEROL; BETA-D-MANNOSE; N-ACETYL-D-GLUCOSAMINE; 2-(1,1'-BIPHENYL-4-YL)PROPANOIC ACID; PROTOPORPHYRIN IX CONTAINING FE; ALPHA-D-MANNOSE"
1QH7,MT,xylanase,1.78,X-Ray,"CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLASES: A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMIDIATE REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS FAMILY 11 XYLANASE",XYP; PCA,BETA-D-XYLOPYRANOSE; PYROGLUTAMIC ACID
1R1H,MT,neprilysin,1.95,X-Ray,STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS,BIR; NAG; ZN,"N-[3-[(1-AMINOETHYL)(HYDROXY)PHOSPHORYL]-2-(1,1'-BIPHENYL-4-YLMETHYL)PROPANOYL]ALANINE; N-ACETYL-D-GLUCOSAMINE; ZINC ION"
1R55,MT,adam 33,1.58,X-Ray,Crystal structure of the catalytic domain of human ADAM 33,ZN; CA; NAG; CL; 097; MAN,"ZINC ION; CALCIUM ION; N-ACETYL-D-GLUCOSAMINE; CHLORIDE ION; (2S,3R)-N~4~-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N~1~,2-DIHYDROXY-3-(2-METHYLPROPYL)BUTANEDIAMIDE; ALPHA-D-MANNOSE"
1RNT,MT,ribonuclease t1 isozyme,1.9,X-Ray,RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF THE RIBONUCLEASE T1(ASTERISK)2(PRIME)-GUANYLIC ACID COMPLEX AT 1.9 ANGSTROMS RESOLUTION,2GP,GUANOSINE-2'-MONOPHOSPHATE
1S3V,MT,dihydrofolate reductase,1.8,X-Ray,Structure Determination of Tetrahydroquinazoline Antifolates in Complex with Human and Pneumocystis carinii Dihydrofolate Reductase: Correlations of Enzyme Selectivity and Stereochemistry,SO4; TQD,"SULFATE ION; (2R,6S)-6-{[METHYL(3,4,5-TRIMETHOXYPHENYL)AMINO]METHYL}-1,2,5,6,7,8-HEXAHYDROQUINAZOLINE-2,4-DIAMINE"
1SG0,MT,nrh dehydrogenase [quinone] 2,1.5,X-Ray,Crystal structure analysis of QR2 in complex with resveratrol,ZN; FAD; STL,ZINC ION; FLAVIN-ADENINE DINUCLEOTIDE; RESVERATROL
1SJ0,MT,estrogen receptor,1.9,X-Ray,Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D,E4D,"(2S,3R)-2-(4-(2-(PIPERIDIN-1-YL)ETHOXY)PHENYL)-2,3-DIHYDRO-3-(4-HYDROXYPHENYL)BENZO[B][1,4]OXATHIIN-6-OL"
1SLN,MT,stromelysin-1,2.27,X-Ray,"CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842",INH; ZN; CA,N-(R-CARBOXY-ETHYL)-ALPHA-(S)-(2-PHENYLETHYL)GLYCYL-L-ARGININE-N-PHENYLAMIDE; ZINC ION; CALCIUM ION
1SNC,MT,thermonuclease precursor,1.65,X-Ray,"THE CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF STAPHYLOCOCCAL NUCLEASE, CA2+, AND THE INHIBITOR PD*TP, REFINED AT 1.65 ANGSTROMS",THP; CA,"THYMIDINE-3',5'-DIPHOSPHATE; CALCIUM ION"
1SQN,MT,progesterone receptor,1.45,X-Ray,Progesterone Receptor Ligand Binding Domain with bound Norethindrone,NDR,"(14BETA,17ALPHA)-17-ETHYNYL-17-HYDROXYESTR-4-EN-3-ONE"
1T40,MT,aldose reductase,1.8,X-Ray,Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5,ID5; NAP,"[5-FLUORO-2-({[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]AMINO}CARBONYL)PHENOXY]ACETIC ACID; NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE"
1T46,MT,homo sapiens v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog,1.6,X-Ray,STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE,PO4; STI,PHOSPHATE ION; 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE
1T9B,MT,"acetolactate synthase, mitochondrial",2.2,X-Ray,"Crystal structure of yeast acetohydroxyacid synthase in complex with a sulfonylurea herbicide, chlorsulfuron",P22; MG; FAD; YF3; 1CS; NSP; P25; POTASSIUM,"ETHYL DIHYDROGEN DIPHOSPHATE; MAGNESIUM ION; FLAVIN-ADENINE DINUCLEOTIDE; 2-{[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]AMINO}PROPANE-1-THIOL; 1-(2-CHLOROPHENYLSULFONYL)-3-(4-METHOXY-6-METHYL-L,3,5-TRIAZIN-2-YL)UREA; 5-(AMINOMETHYL)-2-METHYLPYRIMIDIN-4-AMINE; PENTYL TRIHYDROGEN DIPHOSPHATE; ION"
1THL,MT,thermolysin,1.7,X-Ray,"Thermolysin complexed with a novel glutaramide derivative, n-(1-(2(r,s)-carboxy-4-phenylbutyl) cyclopentylcarbonyl)-(s)-tryptophan",0DB; ZN; CA,N-({1-[(2S)-2-CARBOXY-4-PHENYLBUTYL]CYCLOPENTYL}CARBONYL)-L-TRYPTOPHAN; ZINC ION; CALCIUM ION
1THY,MT,thymidylate synthase,2.9,X-Ray,REFINED STRUCTURES OF SUBSTRATE-BOUND AND PHOSPHATE-BOUND THYMIDYLATE SYNTHASE FROM LACTOBACILLUS CASEI,UMP,2'-DEOXYURIDINE 5'-MONOPHOSPHATE
1TLP,MT,thermolysin,2.3,X-Ray,CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN,ZN; CA; RDF,ZINC ION; CALCIUM ION; N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L-LEUCYL-L-TRYPTOPHAN
1TPP,MT,beta-trypsin,1.4,X-Ray,"THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS",APA; CA; SO4,(2S)-3-(4-CARBAMIMIDOYLPHENYL)-2-HYDROXYPROPANOIC ACID; CALCIUM ION; SULFATE ION
1TZ8,MT,transthyretin,1.85,X-Ray,The monoclinic crystal struture of transthyretin in complex with diethylstilbestrol,ACT; DMS; GOL; DES; CO3,ACETATE ION; DIMETHYL SULFOXIDE; GLYCEROL; DIETHYLSTILBESTROL; CARBONATE ION
1U1C,MT,uridine phosphorylase,2.2,X-Ray,Structure of E. coli uridine phosphorylase complexed to 5-benzylacyclouridine (BAU),PO4; POTASSIUM; BAU,"PHOSPHATE ION; ION; 1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE"
1V48,MT,purine nucleoside phosphorylase,2.2,X-Ray,"Calf spleen purine nucleoside phosphorylase (PNP) binary complex with 9-(5,5-difluoro-5-phosphonopenthyl)guanine",ZN; MG; HA1,"ZINC ION; MAGNESIUM ION; 9-(5,5-DIFLUORO-5-PHOSPHONOPENTYL)GUANINE"
1V4S,MT,glucokinase isoform 2,2.3,X-Ray,Crystal structure of human glucokinase,MRK; NA; GLC,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE; SODIUM ION; ALPHA-D-GLUCOSE"
1VCJ,MT,neuraminidase,2.4,X-Ray,Influenza B virus neuraminidase complexed with 1-(4-Carboxy-2-(3-pentylamino)phenyl)-5-aminomethyl-5-hydroxymethyl-pyrrolidin-2-one,IBA,4-[(2R)-2-(AMINOMETHYL)-2-(HYDROXYMETHYL)-5-OXOPYRROLIDIN-1-YL]-3-[(1-ETHYLPROPYL)AMINO]BENZOICACID
1XOZ,MT,"cgmp-specific 3',5'-cyclic phosphodiesterase",1.37,X-Ray,Catalytic Domain Of Human Phosphodiesterase 5A In Complex With Tadalafil,ZN; CIA; MG,"ZINC ION; 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE; MAGNESIUM ION"
1Y6B,MT,vascular endothelial growth factor receptor 2,2.1,X-Ray,Crystal structure of VEGFR2 in complex with a 2-anilino-5-aryl-oxazole inhibitor,AAX,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE"
1YGC,MT,coagulation factor vii,2,X-Ray,Short Factor VIIa with a small molecule inhibitor,905; CA; SO4,"(R)-4-[2-(3-AMINO-BENZENESULFONYLAMINO)-1-(3,5-DIETHOXY-2-FLUOROPHENYL)-2-OXO-ETHYLAMINO]-2-HYDROXY-BENZAMIDINE; CALCIUM ION; SULFATE ION"
1Z95,MT,androgen receptor,1.8,X-Ray,Crystal Structure of the Androgen Receptor Ligand-binding Domain W741L Mutant Complex with R-bicalutamide,198; SO4,R-BICALUTAMIDE; SULFATE ION
25C8,MT,igg 5c8,2,X-Ray,"CATALYTIC ANTIBODY 5C8, FAB-HAPTEN COMPLEX",GEP,N-METHYL-N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM ION
2ADA,MT,adenosine deaminase,2.4,X-Ray,ATOMIC STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH A TRANSITION-STATE ANALOG: UNDERSTANDING CATALYSIS AND IMMUNODEFICIENCY MUTATIONS,ZN; HPR,"ZINC ION; 6-HYDROXY-7,8-DIHYDRO PURINE NUCLEOSIDE"
2BM2,MT,human beta2 tryptase,2.2,X-Ray,HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,PM2,1-[3-(1-{[5-(2-PHENYLETHYL)PYRIDIN-3-YL]CARBONYL}PIPERIDIN-4-YL)PHENYL]METHANAMINE
2BSM,MT,heat shock protein hsp90-alpha,2.05,X-Ray,"NOVEL, POTENT SMALL MOLECULE INHIBITORS OF THE MOLECULAR CHAPERONE HSP90 DISCOVERED THROUGH STRUCTURE-BASED DESIGN",BSM,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE"
2TPI,MT,trypsinogen,2.1,X-Ray,ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY,HG; ILE; VAL,MERCURY (II) ION; ISOLEUCINE; VALINE
3TPI,MT,trypsinogen,1.9,X-Ray,"THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS",CA; SO4; ILE; VAL,CALCIUM ION; SULFATE ION; ISOLEUCINE; VALINE
4HMG,MT,"hemagglutinin, chain ha1",3,X-Ray,REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING,NAG; SIA; MAN,N-ACETYL-D-GLUCOSAMINE; O-SIALIC ACID; ALPHA-D-MANNOSE
4TMN,MT,thermolysin,1.7,X-Ray,SLOW-AND FAST-BINDING INHIBITORS OF THERMOLYSIN DISPLAY DIFFERENT MODES OF BINDING. CRYSTALLOGRAPHIC ANALYSIS OF EXTENDED PHOSPHONAMIDATE TRANSITION-STATE ANALOGUES,ZN; CA; 0PK,ZINC ION; CALCIUM ION; N-[(S)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-PHENYLETHYL](HYDROXY)PHOSPHORYL]-L-LEUCYL-L-ALANINE
5TIM,MT,triosephosphate isomerase,1.83,X-Ray,"REFINED 1.83 ANGSTROMS STRUCTURE OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE, CRYSTALLIZED IN THE PRESENCE OF 2.4 M-AMMONIUM SULPHATE. A COMPARISON WITH THE STRUCTURE OF THE TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE-GLYCEROL-3-PHOSPHATE COMPLEX",DTT; SO4,"2,3-DIHYDROXY-1,4-DITHIOBUTANE; SULFATE ION"
5TMN,MT,thermolysin,1.6,X-Ray,Slow-and fast-binding inhibitors of thermolysin display different modes of binding. crystallographic analysis of extended phosphonamidate transition-state analogues,0PJ; ZN; CA,N-[(S)-({[(BENZYLOXY)CARBONYL]AMINO}METHYL)(HYDROXY)PHOSPHORYL]-L-LEUCYL-L-LEUCINE; ZINC ION; CALCIUM ION
6TMN,MT,thermolysin,1.6,X-Ray,Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond,0PI; ZN; CA,"N-[(2R,4S)-4-HYDROXY-2-(2-METHYLPROPYL)-4-OXIDO-7-OXO-9-PHENYL-3,8-DIOXA-6-AZA-4-PHOSPHANONAN-1-OYL]-L-LEUCINE; ZINC ION; CALCIUM ION"
1AJ7,NT,immunoglobulin 48g7 fab (light chain),2.1,X-Ray,IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY,NPE,5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1ATL,NT,atrolysin c,1.8,X-Ray,"Structural interaction of natural and synthetic inhibitors with the VENOM METALLOPROTEINASE, ATROLYSIN C (FORM-D)",ZN; CA; 0QI,ZINC ION; CALCIUM ION; O-METHYL-N-[(2S)-4-METHYL-2-(SULFANYLMETHYL)PENTANOYL]-L-TYROSINE
1ETA,NT,transthyretin,1.7,X-Ray,THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION,T44,"3,5,3',5'-TETRAIODO-L-THYRONINE"
1R09,NT,human rhinovirus 14 coat protein (subunit vp1),2.9,X-Ray,HUMAN RHINOVIRUS 14 COMPLEXED WITH ANTIVIRAL COMPOUND R 61837,DMS; JEN,DIMETHYL SULFOXIDE; 3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE
1VGC,NT,gamma chymotrypsin,1.9,X-Ray,GAMMA-CHYMOTRYPSIN L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX,SO4; V36,SULFATE ION; L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID
1VRH,NT,rhinovirus 14,3,X-Ray,HRV14/SDZ 880-061 COMPLEX,SD8,"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER"
2R04,NT,human rhinovirus 14 coat protein (subunit vp1),3,X-Ray,STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES,W71,"5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE"
2R07,NT,human rhinovirus 14 coat protein (subunit vp1),3,X-Ray,STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES,W33,"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE"